Annual Report 2025-26 and the Notice of 37th Annual General Meeting

CIN: L27100TG1989PLC010122 ZENOTECH LABORATORIES LIMITED Registered Office & Factory: Survey No.250 -252 Turkapally Village, Genome Valley Road, Shamirpet Mandal Medchal-Malkajgiri Dist., Hyderabad - 500 101 Telangana, India. Tel: +91 90320 44584/ 585 Email: info@zenotech.co.in www.zenotechlab.com Date: August 28, 2026 BSE Limited, Market Operations Dept. P. J. Towers, Dalal Street, Mumbai-400001. Scrip Code: 532039 Subject: Annual Report 2025-26 and Notice of 37th Annual General Meeting of Zenotech Laboratories Limited (the Company) Further to our communication dated August 22, 2026 and pursuant to Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the Annual Report for the Financial Year 2025-26, including the Notice of Thirty-Seventh Annual General Meeting (“37th AGM”), scheduled to be held on Friday, September 25, 2026 at 10:30 A.M. IST through Video Conferencing. The Annual Report and the Notice of 37th AGM is available on the Company’s website at https://www.zenotechlab.com/annual-reports/ and can also be accessed by scanning the following QR code: The information about key events for the 37th AGM and Remote E-voting is as follows: Timeline Cut-off date (for voting eligibility) Friday, September 18, 2026 Remote E-voting Begins Tuesday, September 22, 2026 at 09:00 A.M. IST Remote E-voting Ends Thursday, September 24, 2026 till 05:00 P.M. IST For ZENOTECH LABORATORIES LIMITED (Abdul Gafoor Mohammad) Company Secretary & Compliance Officer ICSI Membership No.: A22331 Encl: as above Manufacturing facilities & Registered office : Annual Report Survey No. 250-252, Turkapally Village, Genome Valley Road, Shamirpet Mandal, Medchal-Malkajgiri Dist., Hyderabad-500101 2025-26 Telangana, India Phone : +91 90320 44584 / 585 E-mail : info@zenotech.co.in Website : www.zenotechlab.com CIN : L27100TG1989PLC010122 Annual Report 2025-26 ZENOTECH LABORATORIES LIMITED CIN: L27100TG1989PLC010122 Board of Directors Dr. Azadar Husain Asghar Mehdi Khan : Non-Executive Director Jignesh Anantray Goradia : Non-Executive Director Chintan Jitendra Shah : Independent Director (upto January 26, 2026) Jagruti Prashant Sheth : Independent Director Rakeshchandra Jagdishprasad Sinha : Non-Executive Director Premal Hemant Gandhi : Independent Director Nikkhil Venilal Kothhari : Independent Director (Appointed w.e.f. January 23, 2026) Key Managerial Personnel Dr. Sachin Laxmanappa Gavandare : Chief Executive Officer Poly K.V. : Chief Financial Officer Abdul Gafoor Mohammad : Company Secretary & Compliance Officer Manufacturing & Registered Office : Survey No.250-252, Turkapally Village, Genome Valley Road, Shamirpet Mandal, Medchal-Malkajgiri Dist., Hyderabad – 500 101 Telangana, India. Telephone Nos. +91 90320 44584/585 Email Id: info@zenotech.co.in Website: https://www.zenotechlab.com Registrar and Share Transfer Agent : KFin Technologies Limited (formerly, KFin Technologies Private Limited) Selenium Tower B, Plot No. 31 & 32, Gachibowli, Financial District, Nanakramguda, Hyderabad – 500 032 Telangana, India Telephone Nos.: 1800-3454-001 (Toll Free) Email Id: einward.ris@kfintech.com Statutory Auditors : M/s. G S K A & Co., Chartered Accountants 4th Floor, Red Building, Above Shinhan Bank, Boat Club Road, Pune - 411001 Secretarial Auditor : Mr. Mahadev Tirunagari Company Secretary in Practice Hyderabad, Telangana, India. Internal Auditor : V R P S & Co., (formerly, N. Sai Baba & Co., Chartered Accountants Hyderabad, Telangana, India. 37TH ANNUAL GENERAL MEETING Friday, September 25, 2026 at 10:30 A.M Through Video Conferencing (VC) Zenotech Laboratories_2026_Kala.indd 1 27-08-2026 14:07:23 Annual Report 2025-26 Contents Notice of the 37th Annual General Meeting Board’s Report Report on Corporate Governance Management Discussion and Analysis Report Financial Statements Auditors’ Report Balance Sheet Statement of Profit and Loss Statement of changes in Equity Cash Flow Statement Notes forming part of the Accounts Important Communication to Members: Ministry of Corporate Affairs has taken a “Green Initiative in the Corporate Governance” by allowing paperless compliances by the companies and has issued circulars stating that service of notice / documents including Annual Report can be sent by e-mail to its members. To support this green initiative of the Government in full measure, members who have not registered their e-mail addresses, so far, are requested to register their e-mail addresses in respect of electronic holdings with the Depository through their concerned Depository Participants Zenotech Laboratories_2026_Kala.indd 2 27-08-2026 14:07:23 Annual Report 2025-26 NOTICE OF 37TH ANNUAL GENERAL MEETING NOTICE is hereby given that the Thirty-Seventh (37th) Annual General Meeting of the members of Zenotech Laboratories Limited will be held on Friday, September 25, 2026 at 10:30 a.m. IST through Video Conferencing (“VC”), to transact the following business: ORDINARY BUSINESS: Item No. 1: Adoption of Audited Standalone Financial Statements of the Company To receive, consider and adopt the Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2026 and the Reports of the Board of Directors and Auditors thereon. Item No. 2: Re-appointment of Mr. Jignesh Anantray Goradia as a Director, liable to retire by rotation To appoint Mr. Jignesh Anantray Goradia (DIN: 07229899), who retires by rotation and being eligible, has offered himself for re-appointment. SPECIAL BUSINESS: Item No. 3: Approval for Material Related Party Transaction(s) with Sun Pharmaceutical Industries Limited To consider and, if thought fit, to pass the following Resolution as an Ordinary Resolution: “RESOLVED THAT pursuant to the provisions of Regulation 23 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, (‘Listing Regulations’), the applicable provisions of the Companies Act, 2013 read with Rules made thereunder and other applicable provisions, if any, [including any statutory modification(s) or amendment(s) thereto or re-enactment(s) thereof, for the time being in force], the Company’s Policy on Materiality of and Dealing with Related Party Transactions, and subject to such approval(s), consent(s), permission(s) as may be necessary from time to time and based on the approval/ recommendation of the Audit Committee and the Board of Directors of the Company, approval of the Members be and is hereby accorded on an omnibus basis, to the Company for entering into and/or continuing with arrangements / contracts / agreements / transactions (whether by way of an individual transaction or transactions taken together or series of transactions or otherwise) with Sun Pharmaceutical Industries Limited (‘Sun Pharma’), a holding Company/Promoter of the Company, being a related party of the Company, in the ordinary course of business and on an arm’s length basis, for an aggregate amount not exceeding ₹ 200 Crore, for the period from the date of this 37th Annual General Meeting up to the date of 38th Annual General Meeting (both days inclusive), (hereinafter referred to as ‘RPT period’), as set out in the statement annexed to this notice RESOLVED FURTHER THAT for the purpose of giving effect to the above resolution, the Board of Directors (which expression shall include or deemed to include any committee of the Board thereof constituted or to be constituted) be and is hereby authorised on behalf of the Company to do all such acts, deeds, matters and things as it may, in its absolute discretion, deem necessary or desirable for such purpose and with power on behalf of the Company to settle all questions, difficulties or doubts that may arise in regard to implementation of the aforesaid resolution, without being required to seek any further consent or approval of the members of the Company. RESOLVED FURTHER THAT any Key Managerial Personnel of the Company be and is hereby [Showing first 8,000 characters — download PDF for full document]